Increased Concentration of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Predate Onset of Rheumatoid Arthritis

被引:0
|
作者
Johansson, Linda [1 ]
Arlestig, Lisbeth [1 ]
Kokkonen, Heidi [1 ]
Rantapaa-Dahlqvist, Solbritt [2 ]
机构
[1] Umea Univ, Publ Hlth & Clin Med Rheumatol, Umea, Sweden
[2] Umea Univ, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
926
引用
收藏
页数:1
相关论文
共 50 条
  • [31] IDENTIFICATION OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-kappa B LIGAND(RANKL) AND OSTEOPROTEGERIN(OPG) IN AMELOBLASTOMA
    Ha, Woo-Hun
    Hwang, Dae-Seok
    Kim, Yong-Deok
    Shin, Sang-Hun
    Kim, Uk-Kyu
    Kim, Jong-Ryoul
    Chung, In-Kyo
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2007, 33 (02) : 94 - 102
  • [32] Circulating Levels of Receptor Activator of Nuclear Factor kappa-B Ligand (RANKL), but Not Hepatocyte Growth Factor (HGF) Are Altered during Gestational Diabetes Mellitus (GDM)
    Trofimovsky, Elina
    Cocks-Eschler, Deirdre
    Kulina, Georgia
    Mourad, Mirella
    Bagiella, Emilia
    Cheesman, Khadeen C.
    Bergh, Eric
    Vasavada, Rupangi C.
    Garcia-Ocana, Adolfo
    Levy, Carol
    DIABETES, 2015, 64 : A676 - A676
  • [33] Correlation between Receptor Activator of Nuclear Factor-kappa beta Ligand (RANKL), and Osteoprotegerin (OPG) with Cartilage Degradation in Rheumatoid Arthritis Patients
    Hidayat, Rudy
    Isbagio, Harry
    Setyohadi, Bambang
    Setiati, Siti
    ACTA MEDICA INDONESIANA, 2014, 46 (01) : 24 - 29
  • [34] Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression.
    Geusens, P
    Landewe, R
    Dunstan, C
    Gaenero, P
    van der Linden, S
    Boers, M
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S388 - S388
  • [35] Relationship of endothelial function with serum osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) in women with systemic lupus erythematosus (SLE).
    Rhew, Elisa Y.
    Lee, Chin
    Eksarko, Poli
    Chung, Anh
    Price, Heather E.
    Dyer, Alan R.
    Langman, Craig B.
    Pope, Richard M.
    McPherson, David D.
    Ramsey-Goldman, Rosalind
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S271 - S271
  • [36] Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts
    Armada, Luciana
    Marotta, Patricia dos Santos
    Pires, Fabio Ramoa
    Siqueira, Jose F., Jr.
    JOURNAL OF ENDODONTICS, 2015, 41 (08) : 1281 - 1287
  • [37] Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)
    Terpos, Evangelos
    Christoulas, Dimitrios
    Dimopoulos, Meletios-Athanassios
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (11) : 1265 - 1269
  • [38] CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis
    Hidetoshi Tsushima
    Ken Okazaki
    Kohei Ishihara
    Takahiro Ushijima
    Yukihide Iwamoto
    Arthritis Research & Therapy, 17
  • [39] CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis
    Tsushima, Hidetoshi
    Okazaki, Ken
    Ishihara, Kohei
    Ushijima, Takahiro
    Iwamoto, Yukihide
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [40] The Role of the Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Vascular Diseases: A Therapeutic Approach
    Celebi Torabfam, Gizem
    Porsuk, Melis Hazal
    ANGIOLOGY, 2024,